How Pfizer Profited From the Pandemic

The COVID-19 pandemic has given the drugmaker unique weight in determining US health policy. How can the American people push back against this?

STORY AT-A-GLANCE

• The COVID-19 pandemic has been a real boon to Pfizer. Not only has it doubled Pfizer’s annual revenue, it has also given the drugmaker unique weight in determining U.S. health policy — something that concerns even staunch vaccine-pushers like Dr. Paul Offit

• Pfizer’s revenue in 2021 was $81.3 billion — approximately double that of 2020 — …